These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 12535954

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
    McArthur S, Murray HE, Dhankot A, Dexter DT, Gillies GE.
    J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232
    [Abstract] [Full Text] [Related]

  • 3. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC, Zbarsky V, Datla KP, Croucher MJ, Dexter DT.
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [Abstract] [Full Text] [Related]

  • 4. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease.
    Gillies GE, Murray HE, Dexter D, McArthur S.
    Pharmacol Biochem Behav; 2004 Jul; 78(3):513-22. PubMed ID: 15251260
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y, Yoshimura R, Nakai K, Itakura T.
    Brain Res; 2002 Aug 30; 947(2):271-83. PubMed ID: 12176170
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B, Dluzen DE.
    Synapse; 2006 Oct 30; 60(5):354-61. PubMed ID: 16838362
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
    Datla KP, Blunt SB, Dexter DT.
    Mov Disord; 2001 May 30; 16(3):424-34. PubMed ID: 11391735
    [Abstract] [Full Text] [Related]

  • 12. Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.
    Cordellini MF, Piazzetta G, Pinto KC, Delattre AM, Matheussi F, Carolino RO, Szawka RE, Anselmo-Franci JA, Ferraz AC.
    Neurochem Res; 2011 Jun 30; 36(6):955-61. PubMed ID: 21347839
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system.
    Dluzen DE.
    J Neurocytol; 2000 Jun 30; 29(5-6):387-99. PubMed ID: 11424955
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS, Durairajan SS, Lu JH, Wang Y, Xie LX, Kum WF, Koo I, Yung KK, Li M.
    Neurochem Int; 2009 Nov 30; 55(6):414-22. PubMed ID: 19409437
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.